Latest Articles
- Research ArticleOcrelizumab Impairs the Phenotype and Function of Memory CD8+ T CellsA 1-Year Longitudinal Study in Patients With Multiple SclerosisAmandine Mathias, Vasiliki Pantazou, Sylvain Perriot, et al.January 30, 2023
- Research ArticleOcrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple SclerosisSamantha Ho, Eva Oswald, Hoi Kiu Wong, et al.January 26, 2023
- Research ArticleReduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia GravisRodrigo Álvarez-Velasco, Oriol Dols-Icardo, Shaima El Bounasri, et al.January 25, 2023
- Research ArticleEffects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated DiseasesCOPANMO(G)-StudyMartin W. Hümmert, Franziska Bütow, Daria Tkachenko, et al.January 24, 2023
- Research ArticleCAR-T Cell–Mediated B-Cell Depletion in Central Nervous System AutoimmunitySasha Gupta, Milos Simic, Sharon A. Sagan, et al.January 19, 2023
- Research ArticleAnti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating PolyneuropathyXu Zhang, Jun-Ichi Kira, Hidenori Ogata, et al.January 11, 2023
- Editor's CornerN2 Year in ReviewJosep Dalmau, Marinos C. Dalakas, Dennis L. Kolson, et al.January 03, 2023
- Research ArticleRemote Observational Research for Multiple SclerosisA Natural ExperimentRiley Bove, Shane Poole, Richard Cuneo, et al.December 30, 2022
- Clinical/Scientific NoteElsberg Syndrome Secondary to Cytomegalovirus Infection in an Immunocompetent PatientA Case ReportLucie Lefeuvre, Manuel Schibler, Patrice H. LaliveDecember 23, 2022
- Research ArticleNeuroaxonal and Glial Markers in Patients of the Same Age With Multiple SclerosisFloor C. Loonstra, Lodewijk R.J. de Ruiter, Marleen J.A. Koel-Simmelink, et al.December 21, 2022
Pages
Advertisement
Dr. Daniel Friedman and Dr. Sharon Chiang